Science Explorer Back to mapMap
Discussion
Company · Beijing · China

Genecast (China)

genecast.com.cnROR OpenAlex
Research works
100
▼ 11% vs 2018-21
Citations
965
9.7 per fractional work
Top-10% rate
10.7%
all institutions 10.0%
Open access
52%
world 40%
International
8%
world 18%
Genecast (China)

Not ranked overall: Genecast (China) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Genecast (China) work in?

In 2022-now, 71% of research at Genecast (China) is in Health Sciences, 28% in Life Sciences. Its largest fields are Medicine (71%), Biochemistry, Genetics and Molecular Biology (25%), Immunology and Microbiology (3%). It does 2.6× the world's share of Health Sciences.

Health Sciences: 34 fractional works · 71.1% of its workMedicine: 34 fractional works · 70.8% of its workOncology: 14 fractional works · 29.5% of its workPulmonary and Respiratory Medicine: 9 fractional works · 18.7% of its workSurgery: 4 fractional works · 8.3% of its workPathology and Forensic Medicine: 2 fractional works · 3.5% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 2.3% of its workEpidemiology: 1 fractional works · 2.2% of its workOtorhinolaryngology: 1 fractional works · 1.3% of its workRheumatology: 1 fractional works · 1.1% of its workHepatology: 0 fractional works · 0.7% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.7% of its workReproductive Medicine: 0 fractional works · 0.6% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.4% of its workObstetrics and Gynecology: 0 fractional works · 0.4% of its workPhysiology: 0 fractional works · 0.4% of its workGastroenterology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.4% of its workHealth Professions: 0 fractional works · 0.4% of its workGeneral Health Professions: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workLife Sciences: 13 fractional works · 28.2% of its workBiochemistry, Genetics and Molecular Biology: 12 fractional works · 25.3% of its workCancer Research: 7 fractional works · 15.3% of its workMolecular Biology: 4 fractional works · 9.4% of its workGenetics: 0 fractional works · 0.3% of its workCell Biology: 0 fractional works · 0.2% of its workImmunology and Microbiology: 1 fractional works · 2.6% of its workImmunology: 1 fractional works · 2.6% of its workNeuroscience: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 0 fractional works · 0.1% of its workPhysical Sciences: 0 fractional works · 0.7% of its workEngineering: 0 fractional works · 0.2% of its workElectrical and Electronic Engineering: 0 fractional works · 0.2% of its workChemistry: 0 fractional works · 0.2% of its workComputer Science: 0 fractional works · 0.1% of its workPhysics and Astronomy: 0 fractional works · 0.1% of its workALL ITS WORKGenecast (China)47fractional works, 2022-now
Life Sciences28%Physical Sciences1%Health Sciences71%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 10 fields, with their numbers
    1. Medicine3470.8%
    2. Health Professions00.4%
    1. Biochemistry, Genetics and Molecular Biology1225.3%
    2. Immunology and Microbiology12.6%
    3. Neuroscience00.2%
    4. Agricultural and Biological Sciences00.1%
    1. Engineering00.2%
    2. Chemistry00.2%
    3. Computer Science00.1%
    4. Physics and Astronomy00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What does Genecast (China) specialise in?

Where its research is concentrated relative to its size: Medicine takes 3.7× the share of its output that it takes of world research.

  1. MedicineField · 33.6 works3.7×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.02× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.75× its world share, 12 worksBiochemistry, Geneti…Immunology and Microbiology: 2.61× its world share, 1 worksImmunology and Micro…Neuroscience: 0.11× its world share, 0 worksNeuroscienceChemistry: 0.11× its world share, 0 worksChemistryComputer Science: 0.02× its world share, 0 worksComputer ScienceEngineering: 0.02× its world share, 0 worksEngineeringPhysics and Astronomy: 0.05× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.13× its world share, 0 worksHealth ProfessionsMedicine: 3.68× its world share, 34 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 4.8×. Every wedge is a field page.

All 10 fields, with their numbers
  1. Biochemistry, Genetics and Molecular Biology4.75×12 works
  2. Medicine3.68×34 works
  3. Immunology and Microbiology2.61×1 works
  4. Health Professions0.13×0 works
  5. Neuroscience0.11×0 works
  6. Chemistry0.11×0 works
  7. Physics and Astronomy0.05×0 works
  8. Agricultural and Biological Sciences0.02×0 works
  9. Computer Science0.02×0 works
  10. Engineering0.02×0 works

Who are the top researchers at Genecast (China)?

Ranked on the quality score, Ji He, Huaibo Sun and Weizhi Chen lead among researchers whose main affiliation is Genecast (China).

  1. 1 Ji He China · #193,327 worldwide 5.1k citations · 96 works
  2. 2 Huaibo Sun China · #504,687 worldwide 1.6k citations · 32 works
  3. 3 Weizhi Chen China · #514,198 worldwide 2.2k citations · 169 works
  4. 4 Xinying Shi China · #905,354 worldwide 367 citations · 31 works
  5. 5 Longlong Gong China · #1,729,477 worldwide 1.6k citations · 38 works
  6. 6 Hongbo Zheng China · #1,756,557 worldwide 518 citations · 20 works
  7. 7 Ying Yang China · #1,794,260 worldwide 1.1k citations · 73 works
  8. 8 Yuanyuan Hong China · #1,801,467 worldwide 294 citations · 29 works
  9. 9 Tiancheng Han China · #1,829,591 worldwide 172 citations · 21 works
  10. 10 Yu S. Huang China · #1,888,453 worldwide 50 citations · 19 works
All ranked researchers at Genecast (China)

What are the most cited papers from Genecast (China)?

The most cited paper from Genecast (China) is "Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer" (Qingzhu Jia, Wei Wu, Yuqi Wang et al., 2018), with 549 citations. Next come "Tumor neoantigens: from basic research to clinical applications" (404) and "Tislelizumab combined with chemotherapy as neoadjuvant therapy for surgically resectable esophageal cancer: A prospective, single-arm, phase II study (TD-NICE)" (243).

Most cited papers
#PaperReleasedCitations
1 Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer Qingzhu Jia, Wei Wu, Yuqi Wang et al. · Nature Communications Open access 12 Dec 2018 549
2 Tumor neoantigens: from basic research to clinical applications Tao Jiang, Tao Shi, Henghui Zhang et al. · Journal of Hematology & Oncology Open access 6 Sep 2019 404
3 Tislelizumab combined with chemotherapy as neoadjuvant therapy for surgically resectable esophageal cancer: A prospective, single-arm, phase II study (TD-NICE) Xiaolong Yan et al. · International Journal of Surgery 18 May 2022 243
4 Predicting response to immunotherapy in advanced non-small-cell lung cancer using tumor mutational burden radiomic biomarker Bingxi He, Di Dong, Yunlang She et al. · Journal for ImmunoTherapy of Cancer Open access Jul 2020 191
5 Efficacy and Biomarker Analysis of Camrelizumab in Combination with Apatinib in Patients with Advanced Nonsquamous NSCLC Previously Treated with Chemotherapy Caicun Zhou et al. · Clinical Cancer Research 22 Jan 2021 132
All 60 most cited papers, with filters and sorting

Which keywords describe research at Genecast (China)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Targeted Therapy, Chemotherapy, Tumor Microenvironment, Clinical Trials, Cancer Genomics, Mutational Signatures, Immune Checkpoint Blockade and PD-1 and PD-L1.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Targeted Therapy12▲ 115×3 topics
  2. Chemotherapy9▲ 27×12 topics
  3. Tumor Microenvironment9▲ 41×6 topics
  4. Clinical Trials7▲ 21×3 topics
  5. Cancer Genomics6▲ 172×1 topic
  6. Mutational Signatures6▲ 172×1 topic
  7. Immune Checkpoint Blockade6▲ 105×1 topic
  8. PD-1 and PD-L16▲ 105×1 topic
  9. Neoadjuvant Therapy4▲ 37×5 topics
  10. ALK Inhibitors4▲ 138×1 topic
  11. EGFR Mutations4▲ 138×1 topic
  12. Immunotherapy4▲ 12×8 topics
  13. Prognostic Factors4▲ 19×8 topics
  14. Epidemiology3▲ 1.75×7 topics
  15. Cancer3▲ 4.9×12 topics
  16. Metastasis3▲ 18×6 topics
  17. Chemoradiation3▲ 93×2 topics
  18. Gene Expression3▲ 9.6×6 topics
  19. Endoscopic Resection3▲ 60×2 topics
  20. Tumor Markers3▲ 71×2 topics
  21. Biomarkers3▲ 8.0×3 topics
  22. Preoperative Chemoradiotherapy3▲ 70×2 topics
  23. Radiotherapy3▲ 14×3 topics
  24. Surgery3▲ 16×2 topics
  25. Molecular Characterization2▲ 29×4 topics
  26. Clinical Practice Guidelines2▲ 8.6×6 topics
  27. Genomic Profiles2▲ 109×1 topic
  28. Precision Medicine2▲ 9.9×2 topics
  29. Small-Cell Lung Cancer2▲ 109×1 topic
  30. Barrett's Esophagus2▲ 109×1 topic
  31. Esophageal Carcinoma2▲ 109×1 topic
  32. Adjuvant Therapy2▲ 36×2 topics
  33. Cetuximab2▲ 50×2 topics
  34. Molecular Subtypes2▲ 47×2 topics
  35. Survival Analysis2▲ 15×6 topics
  36. Adjuvant Chemotherapy2▲ 54×2 topics
  37. Cell Death2▲ 15×2 topics
  38. Ferroptosis2▲ 40×1 topic
  39. Lipid Peroxidation2▲ 30×1 topic
  40. Tumor Staging2▲ 29×2 topics

Which research topics does Genecast (China) publish most on?

By volume in 2022-now: Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations and Lung Cancer Research Studies.

Cancer Genomics and Diag…6Cancer Genomics and Diagnostics: 6 fractional worksCancer Immunotherapy and…6Cancer Immunotherapy and Biomarkers: 6 fractional worksLung Cancer Treatments and Mutations: 4 fractional worksLung Cancer Research Stu…2Lung Cancer Research Studies: 2 fractional worksEsophageal Cancer Resear…2Esophageal Cancer Research and Treatment: 2 fractional worksFerroptosis and cancer p…2Ferroptosis and cancer prognosis: 2 fractional worksLung Cancer Diagnosis and Treatment: 2 fractional worksEpigenetics and DNA Methylation: 2 fractional worksColorectal Cancer Treatments and Studies: 1 fractional worksGenetic factors in colorectal cancer: 1 fractional works
Cancer ResearchOncologyPulmonary and Respiratory MedicineSurgery2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cancer Genomics and Diagnostics Cancer Research 6 works
  2. 2 Cancer Immunotherapy and Biomarkers Oncology 6 works
  3. 3 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 4 works
  4. 4 Lung Cancer Research Studies Oncology 2 works
  5. 5 Esophageal Cancer Research and Treatment Surgery 2 works
  6. 6 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 2 works
  7. 7 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 2 works
  8. 8 Epigenetics and DNA Methylation Molecular Biology 2 works
  9. 9 Colorectal Cancer Treatments and Studies Oncology 1 works
  10. 10 Genetic factors in colorectal cancer Pathology and Forensic Medicine 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available52.5%not open47.5%

World: 40% of research is openly available.

with international co-authors7.5%domestic only92.5%

World: 18% is written across borders.

How has Genecast (China)'s research output changed?

Output in 2022-2025 was 11% lower than in 2018-2021.

still counting201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Genecast (China) as a percentage of every work published that year, 0.00021% in 2024.

still counting0.00020%0.00040%Genecast (China)0.000093% in 20252020

Fractional works of Genecast (China) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Beijing

All research institutions in Beijing

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Genecast (China). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.